disease interaction(s) of obesity with alcohol abuse

From Aaushi

Jump to navigation Jump to search

^[1]

Management

once-weekly semaglutide beneficial for patients with alcohol use disorder & obesity^[1]

More general terms

disease interaction

References

↑ ^1.0 ^1.1 Kruse Klausen M et al Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial. Lancet. 2026. 407(105400;1687-1698. May 2. Not yet indexed in PubMed https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00305-3/fulltext

Retrieved from "https://aaushi.info/w/index.php?title=A59571&oldid=1295586"

↑ Back to top